Status:
RECRUITING
Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Lead Sponsor:
Kaplan Medical Center
Conditions:
Neutropenia (Low White Blood Cell Count)
Eligibility:
All Genders
1-1 years
Brief Summary
This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples wi...
Detailed Description
This is a prospective, observational cohort study designed to evaluate the prevalence of the Duffy null phenotype (Fya-/Fyb-) and its association with ethnic neutropenia in neonates born at Kaplan Med...
Eligibility Criteria
Inclusion
- Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025
- Parental informed consent obtained
- Umbilical cord blood available for routine testing
Exclusion
- None
Key Trial Info
Start Date :
October 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06908616
Start Date
October 8 2024
End Date
December 31 2027
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kaplan Medical Center
Rehovot, Israel, Israel, 7661041